Prot #42756493BLC3004: MoonRISe-1: A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive

Project: Research project

Project Details

StatusActive
Effective start/end date7/16/24 → 12/31/28

Funding

  • Janssen Research & Development, LLC (Prot #42756493BLC3004)